Merck hands Sutro $60M to start on immunomodulatory drug discovery; Eli Lilly spinning out animal health group
→ Drugs that can tune the human immune system are all the rage these days, especially at Big Pharma R&D groups like Merck’s. And today …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
